About
Dr. Line Delisle is a highly skilled Medical Oncologist and Hematologist, offering expert care in the diagnosis and systemic treatment of both solid tumors and hematologic malignancies. Practicing at CHUS - Hôp Fleurimont in Sherbrooke, QC, she is part of a dedicated healthcare team committed to providing comprehensive cancer care aligned with the standards set by the Collège des médecins du Québec (CMQ). Dr. Delisle offers detailed management strategies for a broad spectrum of cancers and complex hematologic conditions, ensuring that each patient receives personalized, multidisciplinary treatment tailored to their specific needs.
She graduated with a Medical Degree in 1980 and has been practicing as a Medical Oncologist and Hematologist for over 44 years since then. Dr. Delisle completed extensive post-graduate medical training and certification in Medical Oncology and Hematology, specializing in the management of cancer and blood disorders. Her expertise encompasses the latest advances in diagnostic techniques and therapeutic options, reflecting her commitment to excellence in patient-centered care.
Dedicated to providing compassionate and evidence-based care, Dr. Delisle adopts a multidisciplinary approach that emphasizes collaboration with other specialists, supportive care teams, and research initiatives to improve patient outcomes. She is fluent in French and actively supports her patients through empathetic communication, ensuring they feel informed and supported throughout their treatment journey. Her clinical philosophy centers on integrating the most current clinical guidelines with individualized patient care, fostering a supportive environment for adults with suspected or diagnosed cancer or hematologic conditions.
Dr. Line Delisle has expertise in managing a wide range of conditions, including:
Hematologic Malignancies (Blood Cancers) Treated
- Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow, often managed with targeted therapies.
- Acute Myeloid Leukemia (AML): A rapidly progressing cancer of the blood and bone marrow affecting myeloid cells.
- Non-Hodgkin Lymphoma (NHL) (e.g., Diffuse Large B-Cell, Follicular, Mantle Cell): A diverse group of blood cancers that develop from lymphocytes, with many different subtypes requiring tailored treatments.
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Aplastic Anemia & Bone Marrow Failure Syndromes: Rare but serious conditions where the bone marrow doesn't produce enough new blood cells.
- Thrombophilia & Acquired Clotting Disorders (e.g., DVT/PE management, Antiphospholipid Syndrome): Conditions that increase the tendency to form blood clots, requiring anticoagulation therapy and management.
- Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
Common Cancers (Solid Tumors) Treated
- Sarcomas (Bone & Soft Tissue - Systemic Therapy): Rare cancers arising from connective tissues, where medical oncologists administer chemotherapy or targeted therapies for advanced or metastatic disease.
- Genitourinary Cancers (Bladder, Kidney, Testicular, Penile): Cancers affecting the urinary system (kidneys, bladder) or male reproductive organs (testes, penis), managed with chemotherapy, immunotherapy, or targeted agents.
- Colorectal Cancer (Colon & Rectal Cancer): Cancer that starts in the colon or rectum, often managed with surgery, chemotherapy, radiation (for rectal), and targeted therapies.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Line Delisle or your referring physician.
- Integration with Palliative & Supportive Oncology Services: Collaborative care focusing on optimal symptom management, pain control, and psychosocial support throughout the cancer journey.
- Diagnosis & Treatment of Lymphomas (Hodgkin & Various Non-Hodgkin Subtypes): Tailored treatment strategies for cancers of the lymphatic system, including chemotherapy, immunotherapy, targeted agents, and radiotherapy coordination.
- Systemic Anti-Cancer Therapies Administration & Management: Expert administration and ongoing management of treatments including intravenous and oral chemotherapy, immunotherapy (e.g., checkpoint inhibitors, CAR T-cell therapy coordination), targeted molecular therapy, and hormone therapy.
- Iron Overload Disorders (e.g., Hereditary Hemochromatosis) Management: Monitoring and treatment, including therapeutic phlebotomy, for conditions of excess iron storage.
- Adjuvant, Neoadjuvant, & Metastatic/Palliative Systemic Therapy: Developing treatment plans given before (neoadjuvant) or after (adjuvant) primary local treatment (like surgery or radiation) to improve outcomes, or for managing advanced/metastatic cancer to control disease and improve quality oflife.
- Diagnosis & Management of Multiple Myeloma, Waldenström's Macroglobulinemia & Other Plasma Cell Dyscrasias: Specialized care for cancers arising from plasma cells, utilizing novel agents, chemotherapy, and supportive care, including stem cell transplant coordination.
- Management of Clotting Disorders / Thrombophilia (Inherited & Acquired): Diagnosis, anticoagulation therapy, and long-term management for conditions predisposing to abnormal blood clots (e.g., DVT, PE, Factor V Leiden, Antiphospholipid Syndrome).
Note: This list provides a general overview of services offered in Medical Oncology and Hematology (Cancer and Blood Disorders). Treatment plans are highly individualized. Dr. Delisle provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Delisle or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Delisle's practice is based at the CHUS - Hôp Fleurimont, located in the Fleurimont West (Hospital Area) neighborhood of Sherbrooke. The hospital is conveniently situated near the Marché de la Gare, making it accessible for patients from various parts of the city. Public transportation options are available through the Société de transport de Sherbrooke (STS), providing easy access for those relying on transit services. The facility is wheelchair accessible, ensuring barrier-free access for all patients. Parking is available at the hospital, with designated spaces for visitors and patients, facilitating a convenient visit experience for individuals receiving outpatient or inpatient care.
- Are consultations and treatments with Dr. Delisle, an Medical Oncologist and Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Medical Oncologist and Hematologist such as Dr. Delisle are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Delisle's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Delisle, an Medical Oncologist and Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Medical Oncologist and Hematologist like Dr. Delisle for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What are common side effects of chemotherapy, and how does Dr. Delisle help manage them?
- Chemotherapy can cause various side effects, which differ depending on the specific drugs used, the dose, and individual patient factors. Common ones include fatigue, nausea, vomiting, hair loss, mouth sores, changes in appetite, diarrhea or constipation, and increased risk of infection due to low blood counts. Dr. Delisle and the oncology nursing team will discuss potential side effects of your specific treatment plan in detail and will actively work to prevent and manage them with medications (e.g., anti-nausea drugs, growth factors to boost blood counts), supportive care advice (nutrition, hydration, rest), and regular monitoring. Open communication about any side effects you experience is very important for effective management.
- What can I expect at my first appointment with an Oncologist/Hematologist?
- Your first appointment with Dr. Delisle will be comprehensive and may last an hour or more. It will involve a detailed review of your medical history, family history of cancer, current symptoms, medications, and any previous tests, imaging results (CT, MRI, PET scans), and biopsy reports related to your diagnosis. She will likely perform a thorough physical examination. The main goals are to confirm your diagnosis, discuss the type and stage of your condition (if applicable), and outline potential treatment options. This is a crucial time to ask questions, and you are encouraged to bring a family member or friend for support and to help take notes. Dr. Delisle will explain the proposed treatment plan, including goals, benefits, potential side effects, duration, and what to expect moving forward. Further tests may be ordered.
CHUS - Hôp Fleurimont
3001 12e Avenue N
Sherbrooke, QC J1H 5N4
Phone: (819) 346-1110
The facility is wheelchair accessible.
Dr. Delisle is a licensed Medical Oncologist and Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=80349